Literature DB >> 35459353

Amiodarone induced pulmonary toxicity.

Martin Hudec, Petra Vysočanová, Vojtěch Brázdil, Martin Poloczek, Martin Hetmer, Martina Doubková, Petr Kala.   

Abstract

Amiodarone is one of the more frequently used drugs in the treatment of supraventricular and ventricular arrhythmias. Many adverse effects, more or less serious, are associated with its administration. Amiodaron-induced pulmonary toxicity (AIPT) is quite rare but represents one of the most severe adverse effects with high mortality. We present an 80 years old patient, who used amidorane due to paroxysmal atrial fibrillation for several years. Within 3 months, he was repeatedly hospitalized for a bilateral pneumonia. Eventually, AIPT was diagnosed. Early diagnosis, proper therapy of AIPT and changed antiarrhythmic therapy has significantly improved the clinical status of our patient. In this case we demonstrate typical clinical presentations of AIPT as well as the most common diagnostic procedures and recommended treatment methods. Finally, some other commonly used therapeutical options for supraventricular arrhythmias are mentioned. Future options are outlined.

Entities:  

Keywords:  AIPT; amiodarone; amiodarone induced pulmonary toxicity; amiodarone lung

Mesh:

Substances:

Year:  2021        PMID: 35459353

Source DB:  PubMed          Journal:  Vnitr Lek        ISSN: 0042-773X


  1 in total

1.  Protective Role of Amiodarone on Reperfusion Arrhythmia in Patients of Acute Myocardial Infarction with Percutaneous Coronary Intervention Treatment.

Authors:  Jianying Wang; Jinchang Leng; Xiaowei Sun; Kun Peng; Xaojuan Ma; Shiqin Huang; Fang Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-26       Impact factor: 2.650

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.